The Benchmark Recovery Stack
TB-500 + BPC-157, also known as the wolverine stack, combines systemic cell migration and angiogenesis from TB-500 with the localised structural-repair, gut-protection, and inflammatory-resolution pathways studied for BPC-157. Published studies have examined the blend for tendon and musculoskeletal recovery beyond either peptide alone.
Product
Research shows
Practical product identifiers and format details for professional review.
Content
15 mg
Format
Blend
Composition
5 mg/ml per ml
TB-500 sequesters G-actin, enables cell migration to injury sites, promotes angiogenesis via VEGF upregulation, and reduces pro-inflammatory cytokines. BPC-157 activates FAK-paxillin pathways and the nitric-oxide system in tendon, ligament, and gut-repair research; it also modulates dopaminergic and serotonergic neurotransmission. Combination studies have reported improved Achilles-tendon recovery versus either peptide alone, including faster biomechanical recovery and reduced inflammatory histology.
Based on published research and preclinical data. All benefits are documented under research-grade conditions.
TB-500 provides the mobilisation signal (cells to injury site), BPC-157 provides the structural rebuild (collagen, blood vessels, nerve repair). Together they address both phases of tissue recovery.
The combination has been specifically studied in tendon injury models with results superior to either peptide alone: making it the benchmark protocol for sports injury, post-surgical, and chronic overuse recovery.
BPC-157's gastroprotective and anti-ulcer properties complement TB-500's systemic anti-inflammatory effects, providing comprehensive protection for partners using peptides alongside demanding training or pharmaceutical protocols.
Explore selected publications and registered trials on TB-500 + BPC-157, with links to the original sources.
5 publications from the research library.
Evidence type
Publication and key finding
Source
Evidence type
Evidence synthesis
BPC-157 component systematic review
Publication and key finding
A systematic review of orthopaedic BPC-157 research found consistent improvements in tendon, ligament, muscle and bone-healing outcomes across the included preclinical studies.
HSS journal : the musculoskeletal journal of Hospital for Special Surgery
Evidence type
Preclinical study
BPC-157 component Achilles-tendon preclinical evidence
Publication and key finding
In rats with transected Achilles tendons, BPC-157 accelerated functional and structural healing and stimulated tendocyte growth in laboratory experiments.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society
Evidence type
Preclinical study
TB-500-related Thymosin beta-4 component preclinical evidence
Publication and key finding
In full-thickness rat wounds, thymosin beta-4 increased re-epithelialization by up to 61%, collagen deposition and angiogenesis.
The Journal of investigative dermatology
Evidence type
Review
TB-500-related Thymosin beta-4 component review
Publication and key finding
This review links thymosin beta-4 to cell migration, angiogenesis, reduced inflammation and repair across multiple injury models.
Trends in molecular medicine
Evidence type
Preclinical study
Foundational BPC-157 component preclinical evidence
Publication and key finding
Early animal studies reported that BPC-157 protected gastric and duodenal tissue and produced anti-inflammatory effects across acute injury models.
Life sciences
5 selected studies from the wider trial library, in the order chosen for this product.
NCT00382174
NCT00832091
NCT01387347
NCT01393132
NCT04555824
Combinations used in research protocols where TB-500 + BPC-157 complements other compounds.
TB-500 + BPC-157 + GHK-Cu
Complete repair trinity: systemic mobilisation, structural regeneration, and collagen quality optimisation for the most comprehensive healing protocol available.
View TB-500TB-500 + BPC-157 + Ipamorelin
Recovery and growth hormone support: the combo handles acute tissue repair while Ipamorelin drives the anabolic environment needed for full tissue remodelling.
View TB-500Labbieux pens are designed for 30 to 31 administrations of 10 clicks. With daily use, this corresponds to approximately one month. We recommend starting with 5 clicks and building up to 10 clicks per administration. More sensitive people may use fewer clicks.
Before using our pens, consult the manual.
This public COA documents one selected production batch and is updated annually. It is not the COA for our latest available batch. Every batch has its own documentation, and partners can request the latest batch COA from our team.
Other products from the same range
